News & Updates

Criteria used affects diagnostic outcome in fevers of unknown origin

15 Dec 2024

Applying either the qualitative or the quantitative criteria of fever of unknown origin (FUO) appears to over- or underestimate infectious diseases and undiagnosed illnesses when using an International Classification of Diseases, 10th edition (ICD-10)-adjusted FUO five-category system.

Criteria used affects diagnostic outcome in fevers of unknown origin

15 Dec 2024

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

12 Dec 2024

At a recent Pfizer-sponsored webinar, Dr Paula Ramirez Galleymore, an Intensive Care Medicine specialist from La Fe University and Polytechnic Hospital in Valencia, Spain, addressed the pressing issue of invasive candidiasis in the ICU — often an overlooked but frequent intruder in critical care settings. Galleymore discussed key aspects, including the primary risk factors associated with invasive Candida infections, emphasizing the need for early intervention to improve patient outcomes. She also explored antifungal treatment options, focusing on the clinical efficacy and guideline recommendations for echinocandins.

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

12 Dec 2024

Advancing management of invasive mould disease: Expert insights and practical case study

11 Dec 2024

Invasive mould diseases (IMD), such as invasive aspergillosis or mucormycosis, present significant diagnostic and management challenges, particularly in high-risk patients. A recent Pfizer-sponsored symposium brought together leading experts to discuss current guideline recommendations, diagnostic strategies, and therapeutic approaches to IMD. Chaired by Dr Asok Kurup, Infectious Diseases Physician and Chair of the Infection Control Committee at Mount Elizabeth Hospital, Singapore, the session featured a presentation by Professor Deborah Marriott, Senior Specialist in Clinical Microbiology and Infectious Diseases, St. Vincent’s Hospital in Australia. The symposium provided practical, evidence-based strategies to improve outcomes for high-risk patients and advance IMD care.

Advancing management of invasive mould disease: Expert insights and practical case study

11 Dec 2024

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

The post-pandemic burden of COVID-19 remains significant in adults. Four studies from IDWeek 2024 highlight the benefits of nirmatrelvir-ritonavir (NMV/r) for high-risk adults with SARS-CoV-2 immunity and link chronic conditions to COVID-19 hospitalization. Identifying high-risk patients and using NMV/r in outpatient settings can reduce severe outcomes.

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

BPaLM regimen looks good for drug-resistant TB in children, adults

09 Dec 2024 by

A therapeutic regimen comprising bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) appears to work against drug-resistant tuberculosis (TB) both in paediatric and adult patients, according to two small studies conducted in Indonesia.

BPaLM regimen looks good for drug-resistant TB in children, adults

09 Dec 2024

Clinical considerations for patients at high risk for progression to severe COVID-19

07 Dec 2024

COVID-19 has not gone away. New contagious variants continue to be a leading cause of death, with underlying conditions still influencing the risk of COVID-19 hospitalizations, said Dr Ali Hassoun, Clinical Professor of Medicine and infectious disease specialist at Crestwood Medical Center, Huntsville, Alabama, US, who spoke at a Pfizer-sponsored session during IDWeek 2024.

Clinical considerations for patients at high risk for progression to severe COVID-19

07 Dec 2024

RSV places strain on HK’s public health system, but vaccination reduces burden

06 Dec 2024 by

Respiratory syncytial virus (RSV)-associated infections in older adults impose a substantial economic burden on Hong Kong’s public health system, but the good news is that this burden may be mitigated by vaccination.

RSV places strain on HK’s public health system, but vaccination reduces burden

06 Dec 2024

Original New Drug Application Approvals by US FDA (16-30 November 2024)

06 Dec 2024

New drug applications approved by US FDA as of 16-30 November 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 November 2024)

06 Dec 2024

Crowding, mobility predict TB infection among kids

04 Dec 2024

A high prevalence of tuberculosis (TB) infection is seen among children and adolescents residing in rural Uganda, a study has found. Crowding and mobility are some of the factors associated with TB risk.

Crowding, mobility predict TB infection among kids

04 Dec 2024

Low BMD predicts death, infections in stroke patients

04 Dec 2024

Stroke patients who have low bone mineral density (BMD), particularly in the spine and femur, are at greater risk of mortality and urinary tract infection (UTI), reveals a study.

Low BMD predicts death, infections in stroke patients

04 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Criteria used affects diagnostic outcome in fevers of unknown origin

Criteria used affects diagnostic outcome in fevers of unknown origin

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

Advancing management of invasive mould disease: Expert insights and practical case study

Advancing management of invasive mould disease: Expert insights and practical case study

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

BPaLM regimen looks good for drug-resistant TB in children, adults

BPaLM regimen looks good for drug-resistant TB in children, adults

Clinical considerations for patients at high risk for progression to severe COVID-19

Clinical considerations for patients at high risk for progression to severe COVID-19

RSV places strain on HK’s public health system, but vaccination reduces burden

RSV places strain on HK’s public health system, but vaccination reduces burden

Original New Drug Application Approvals by US FDA (16-30 November 2024)

Original New Drug Application Approvals by US FDA (16-30 November 2024)

Crowding, mobility predict TB infection among kids

Crowding, mobility predict TB infection among kids

Low BMD predicts death, infections in stroke patients

Low BMD predicts death, infections in stroke patients